Financial statements Biogened
Cash flow statement of Biogened
Company age:
Age:
18 y. 10 m. 3 d.
Share capital:
Share capital:
7 415 300 PLN
Cash inflows of BIOGENED
|
Year
|
2018
|
2019
|
2021
|
2023
|
|---|---|---|---|---|
| Net cash from operating expenses | 3 699 432,92 | 5 540 673,42 | 3 141 161,04 | 14 872 133,35 |
| Net cash flow from investing activities | -4 123 715,52 | -3 666 612,41 | -1 081 286,84 | -7 153 651,10 |
| Net cash flow from financial activities | 451 366,54 | -1 733 935,49 | 357 067,41 | -3 661 142,74 |
| Total net cash flow | 27 083,94 | 140 125,52 | 2 416 941,61 | 4 057 339,51 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.